BrainOmega opens €2M round to scale AI drug and RNA discovery
The Barcelona-based Generative AI company, which designs and evaluates new medicines in software, is opening a €2 million funding round, sized for the next 30 months, and welcomes conversations with professional investors.
Read the announcement: BrainOmega opens €2M round to scale AI drug and RNA discovery